Our observation that non-R132H IDH1/2-mutated 1p/19q non-codeleted gliomas have a more favourable prognosis than their IDH1R132H mutated counterpart is clinically relevant and should be taken into account for patient prognostication. Here, IDH1 is linked to central nervous system cancer.